Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
read more
Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline.
read more
Regeneron and Zai Lab announced a collaboration for the development and commercialization of REGN1979 in mainland China, Hong Kong, Taiwan and Macau.
read more
Wednesday, April 08, 2020
The U.S. Food and Drug Administration (FDA) has released the following statement regarding the current compounding policy.
read more
Wednesday, April 08, 2020
The FDA approved the first generic of Proventil HFA Metered Dose Inhaler, 90 mcg/Inhalation, for treatment or prevention of bronchospasm.
read more
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore being considered as possible treatment for COVID-19.
read more
Zymewire announced the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.
read more
Wednesday, April 01, 2020
I-Mab announced a strategic partnership with Kalbe Genexine Biologics.
read more
Wednesday, April 01, 2020
Horizon Discovery and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
read more
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
Wednesday, March 25, 2020
Hoth has reached an agreement with Voltron to form a joint venture entity to commence preclinical studies for the development of vaccine prospects to prevent, intercept or treat the COVID-19.
read more
Akers Biosciences has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by Premas.
read more
Mylan has restarted production of hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility.
read more
The Medical CBRN Defense Consortium has released a RFI seeking solutions to combat the novel Coronavirus pandemic.
read more
Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response.
read more